Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1113 | Pituitary and Neuroendocrinology 3 | ECE2019

The impact of clomiphene citrate as add-on therapy in male acromegalic patients non-responsive to combined medical therapy

Vilar Lucio , Vilar Clarice , Albuquerque Luciano , Trovao Erik , The Ana Carolina , Gadelha Patricia , Campos Renata , Cardoso Izabela , Borges Thaise , Lyra Ruy

Introduction: Clomiphene citrate (CC), a selective estrogen receptor modulator that increases LH and FSH secretion, improves hypogonadism and fertility outcomes. Moreover, there is limited evidence that it may also be helpful as add-on therapy to normalize IGF-1 levels in male acromegalic patients.Objective: To assess the effect impact of CC on serum IGF-1 and testosterone levels in male acromegalic patients not controlled by the combination of lanreotid...